Fritextsökning
Artiklar per år
Innehållstyper
-
He will be the new chair of Medicon Valley Alliance
Niels Abel Bonde is the nomination committee’s proposal and the most likely person to take over as the new chairman of the Swedish-Danish life science cluster organisation Medicon Valley Alliance (MVA).
-
Neogap rekryterar medicinsk chef
Bioteknikbolaget Neogap Therapeutics har utsett Hanjing Xie till Chief Medical Officer. Hennes uppgift blir att leda företagets utvecklingsprogram och första kliniska studie.
-
KI’s new President: “We need to work closer together”
A closer link between research and education and a stronger “we-feeling” are aims that Annika Östman Wernerson sets out to achieve as the new President of Karolinska Institutet. She will not give up her research entirely though. “I think it’s crucial to maintain a close presence in the business,” she says.
-
Meeting with focus on South Korea and Japan’s life sciences
Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage during a webcast seminar.
-
Den enes snor blir den andres bot
Snortransplantation – ordet ger rysningar. Nu presenteras en studie där skånska patienter med kronisk tjock snuva, förbättrades efter att ha använt nässprej innehållande snor från en närstående person med frisk näsa.
-
Major advances in IVF labs in the last few decades
Since the introduction of in vitro fertilisation several decades ago, many developments have been made in the field, and the main part of that development has taken place in the lab.
-
“I am driven by the desire to develop a product that can be sold worldwide”
Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forward in the pursuit of the world’s first ETEC vaccine. Meet the company’s CEO Björn Sjöstrand.
-
Column: ”Cheating with pea flowers and does it matter whether you are right?”
Is it possible to forgive shortcuts or outright cheating in science - if it turns out that the researcher was ultimately right? Anna Törner discuss this topic in a column.
-
Nytt namn till Hansa Biopharma
Lundaföretaget Hansa Biopharma har utsett Matthew Shaulis till Chief Commercial Officer och President för dotterföretaget i USA.
-
Ny COO på Immunovia
Karl Stone, grundare av Oxford Gene Technology och tidigare verksamhetschef på Medicines Discovery Catapult, Lighthouse Lab, tar nu steget in i Immunovias ledningsgrupp som Chief Operating Officer, COO.
-
Bioarctic anställer ny CFO
Bioarctic har nu rekryterat Anders Martin-Löf till ny Chief Financial Officer.
-
The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality
Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Experts in the field claim that andrology needs to become a speciality in Sweden to increase awareness and knowledge. But the Swedish National Board of Health and Welfare says that it is not a priority.
-
“An entire industry is about to be wiped out”
According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.
-
How critical are the “Spermageddon” reports? – Researchers call for action
A much talked about meta-study indicates that sperm concentration in men’s seminal fluid has halved in 40 years. Experts in andrology that Life Science Sweden speaks to believe that the results must be taken seriously, and call for action from the Swedish authorities.
-
Hon är ny medicinsk chef på Medivir
Forskningsbolaget Medivir har anställt Pia Baumann som Chief Medical Officer. Hon kommer bland annat att få det övergripande ansvaret för den kliniska utvecklingen av läkemedelskandidaten fostrox mot levercancer.
-
New issue of Life Science Sweden!
The international issue of Life Science Sweden has been sent to press.
-
Editorial: ”AI that both impresses and frightens”
”In the past, I've rarely been particularly impressed by something that was produced by AI. But this is something completely different”, Samuel Lagercrantz writes in an editorial.
-
Nya namn när Navinci Diagnostics satsar framåt
Uppsalabaserade Navinci Diagnostics har utsett Eva Pisa till ny styrelseordförande, och anställt Caroline Gallant som ny Chief Technology officer. Dessutom har bolaget tillsatt ett nytt vetenskapligt råd.
-
Hello Jenni Nordborg!
Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.
-
A surprising discovery about the immune system in cases of cancer
Professor Göran Jönsson is trying to understand why some patients benefit from immunotherapies while others don’t. A couple of years ago, he made a surprising discovery about the function of the immune system.
-
Rapid development in blood analysis – “Sweden is leading the race”
Thousands of analytical tests using just one single drop of blood. What was revealed as a hoax just a few years ago is now a reality, according to KTH professor and serial entrepreneur Mathias Uhlén.
-
Column: ”Authentic leadership and clear mandates pave the way for more female CEOs”
”I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further”, Helena Strigård writes in a column.
-
Hon får ny roll inom Alligator
Lundbaserade immunterapibolaget Alligator Bioscience har utsett Laura von Schantz till Chief Technology Officer och medlem av företagets ledningsgrupp.
-
Individual DNA passport could result in fewer drug side effects
You may be required to show a DNA passport when you pick up medicines at the pharmacy in the future. According to a new study, patients might suffer 30% fewer side effects if the drug treatment is adapted to their genes.